Pharma-Bio Service is categorized under Business Consultants in Plymouth Meeting, PA .
Pharma-Bio Service was established in 0, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Business Consultants business, which does work in the B2B market, and is classified as a Business Consultants, under code number 5413301 by the NAICS.
If you are seeking more information, feel free to contact Dawn Martin at the company’s single location by writing to 545 West Germantown Pike # 200, Plymouth Meeting, Pennsylvania PA 19462 or by phoning (215) 997-3310. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Pharma-Bio Service |
| Contact Person: | Dawn Martin |
| Address: | 545 West Germantown Pike # 200, Plymouth Meeting, Pennsylvania 19462 |
| Phone Number: | (215) 997-3310 |
| Website Address: | pharmabioserv.com |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Business Consultants |
| SIC Code: | 8748 |
| NAICS Code: | 5413301 |
| Share This Business: |
Pharma-Bio Service was started in 0 to provide professional Business Consultants under the SIC code 8748 and NAICS code 5413301. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Dawn Martin for inquiries that concern Pharma-Bio Service by calling the company number (215) 997-3310, as your correspondence is most welcome. Additionally, the physical location of the single location of Pharma-Bio Service can be found at the coordinates 40.11713,-75.2861 as well as the street address 545 West Germantown Pike # 200 in Plymouth Meeting, Pennsylvania 19462.
For its online presence, you may visit Pharma-Bio Service’s website at pharmabioserv.com and engage with its social media outlets through on Twitter and on Facebook.